Catalent, Inc. (CTLT)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch CTLT
See up to 3 months of CTLT. The 7-day demo opens the 1M and 3M ranges and puts CTLT on your watchlist.
Start 7-day demoLatest CTLT insider trades
About Catalent, Inc. (CTLT)
The SEC lists Catalent, Inc. under CIK 0001596783, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
CTLT Form 4 activity by transaction type, last 90 days
No Form 4 activity for CTLT in the last 90 days.
CTLT insider transactions (Form 4)
7032 Form 4 filings on record, the earliest from Oct 21, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Scott Gunther - Officer | Derivative | Common Stock | 39,635 | - | - | |
| Scott Gunther - Officer | Grant or award | Common Stock | 12,938 | $0.00 | - | |
| Scott Gunther - Officer | Derivative | Common Stock | 12,938 | - | - | |
| Ricky Hopson - Officer | Derivative | Common Stock | 29,974 | - | - | |
| Ricky Hopson - Officer | Grant or award | Common Stock | 10,722 | $0.00 | - | |
| Ricky Hopson - Officer | Derivative | Common Stock | 10,722 | - | - | |
| Ricky Hopson - Officer | Derivative | Options to purchase Common Stock | 1,550 | - | - | |
| Ricky Hopson - Officer | Derivative | Options to purchase Common Stock | 2,622 | - | - | |
| Ricky Hopson - Officer | Derivative | Options to purchase Common Stock | 3,650 | - | - | |
| Ricky Hopson - Officer | Derivative | Options to purchase Common Stock | 3,055 | - | - | |
| Ricky Hopson - Officer | Derivative | Options to purchase Common Stock | 2,565 | - | - | |
| Ricky Hopson - Officer | Derivative | Options to purchase Common Stock | 2,828 | - | - | |
| Ricky Hopson - Officer | Derivative | Options to purchase Common Stock | 10,669 | - | - | |
| Aristippos Gennadios - Officer | Derivative | Common Stock | 113,724 | - | - | |
| Aristippos Gennadios - Officer | Grant or award | Common Stock | 21,562 | $0.00 | - | |
| Aristippos Gennadios - Officer | Derivative | Common Stock | 21,562 | - | - | |
| David McErlane - Officer | Derivative | Common Stock | 36,304 | - | - | |
| David McErlane - Officer | Grant or award | Common Stock | 11,426 | $0.00 | - | |
| David McErlane - Officer | Derivative | Common Stock | 11,426 | - | - | |
| David McErlane - Officer | Derivative | Option to purchase Common Stock | 14,740 | - | - | |
| Michael Hatzfeld - Officer | Derivative | Common Stock | 13,532 | - | - | |
| Michael Hatzfeld - Officer | Grant or award | Common Stock | 3,144 | $0.00 | - | |
| Michael Hatzfeld - Officer | Derivative | Common Stock | 3,144 | - | - | |
| Joseph Anthony Ferraro - Officer | Derivative | Common Stock | 23,967 | - | - | |
| Joseph Anthony Ferraro - Officer | Grant or award | Common Stock | 14,265 | $0.00 | - | |
| Joseph Anthony Ferraro - Officer | Derivative | Common Stock | 14,265 | - | - | |
| Michelle R. Ryan | Derivative | Common Stock | 10,835 | - | - | |
| Stephanie Okey | Derivative | Common Stock | 12,635 | - | - | |
| Steven Barg | Derivative | Common Stock | 12,374 | - | - | |
| Michael J. Barber | Derivative | Common Stock | 18,052 | - | - | |
| Alessandro Maselli - Officer | Derivative | Common Stock | 177,521 | - | - | |
| Alessandro Maselli - Officer | Grant or award | Common Stock | 113,224 | $0.00 | - | |
| Alessandro Maselli - Officer | Derivative | Common Stock | 113,224 | - | - | |
| Alessandro Maselli - Officer | Derivative | Options to purchase Common Stock | 11,093 | - | - | |
| Alessandro Maselli - Officer | Derivative | Options to purchase Common Stock | 10,375 | - | - | |
| Alessandro Maselli - Officer | Derivative | Options to purchase Common Stock | 10,523 | - | - | |
| Alessandro Maselli - Officer | Derivative | Options to purchase Common Stock | 13,735 | - | - | |
| Alessandro Maselli - Officer | Derivative | Options to purchase Common Stock | 15,395 | - | - | |
| Alessandro Maselli - Officer | Derivative | Options to purchase Common Stock | 15,568 | - | - | |
| Alessandro Maselli - Officer | Derivative | Options to purchase Common Stock | 44,427 | - | - | |
| Alessandro Maselli - Officer | Derivative | Options to purchase Common Stock | 103,360 | - | - | |
| Lisa Evoli - Officer | Derivative | Common Stock | 39,366 | - | - | |
| Lisa Evoli - Officer | Grant or award | Common Stock | 12,032 | $0.00 | - | |
| Lisa Evoli - Officer | Derivative | Common Stock | 12,032 | - | - | |
| Lisa Evoli - Officer | Derivative | Options to purchase Common Stock | 14,225 | - | - | |
| Matti Masanovich - Officer | Derivative | Common Stock | 76,475 | - | - | |
| Matti Masanovich - Officer | Grant or award | Common Stock | 71,691 | $0.00 | - | |
| Matti Masanovich - Officer | Derivative | Common Stock | 71,691 | - | - | |
| Matti Masanovich - Officer | Derivative | Options to purchase Common Stock | 81,082 | - | - | |
| J. Martin Carroll | Derivative | Common Stock | 32,734 | - | - | |
| John J. Greisch - Officer | Derivative | Common Stock | 79,932 | - | - | |
| John J. Greisch - Officer | Derivative | Common Stock | 34,000 | - | - | |
| John J. Greisch - Officer | Grant or award | Common Stock | 33,530 | $0.00 | - | |
| John J. Greisch - Officer | Derivative | Common Stock | 33,530 | - | - | |
| John J. Greisch - Officer | Derivative | Options to purchase Common Stock | 127,096 | - | - | |
| Gregory T. Lucier | Derivative | Common Stock | 36,914 | - | - | |
| Donald E. Morel Jr. | Derivative | Common Stock | 70,118 | - | - | |
| Frank A. Damelio | Derivative | Common Stock | 12,635 | - | - | |
| Rolf A. Classon | Derivative | Common Stock | 47,984 | - | - | |
| Jack L. Stahl | Derivative | Common Stock | 47,984 | - | - | |
| Michelle R. Ryan - Director | Open-market sale | Common Stock | 2,800 | $59.70 | $167K | |
| Steven Barg - Director | Grant or award | Common Stock | 4,663 | $0.00 | - | |
| Michelle R. Ryan - Director | Grant or award | Common Stock | 4,663 | $0.00 | - | |
| Stephanie Okey - Director | Grant or award | Common Stock | 4,663 | $0.00 | - | |
| Michael J. Barber - Director | Grant or award | Common Stock | 4,663 | $0.00 | - | |
| J. Martin Carroll - Director | Grant or award | Common Stock | 4,663 | $0.00 | - | |
| Gregory T. Lucier - Director | Grant or award | Common Stock | 4,663 | $0.00 | - | |
| Donald E. Morel Jr. - Director | Grant or award | Common Stock | 4,663 | $0.00 | - | |
| Frank A. Damelio - Director | Grant or award | Common Stock | 4,663 | $0.00 | - | |
| Rolf A. Classon - Director | Grant or award | Common Stock | 4,663 | $0.00 | - |
CTLT insider trading FAQ
What is the latest insider trade for CTLT?
Catalent, Inc. (CTLT) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-12-18. The full record for CTLT runs to 32 Form 4 filings, the earliest from 2024-10-21. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CTLT stock?
No insider purchases of CTLT were filed in the last 90 days.
How many insiders are selling CTLT stock?
No insider sales of CTLT were filed in the last 90 days. 2 sales are on record for this company.
Where can I see CTLT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CTLT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Scott Gunther view on EDGAR
- - Ricky Hopson view on EDGAR
- - Aristippos Gennadios view on EDGAR
- - David McErlane view on EDGAR
- - Michael Hatzfeld view on EDGAR
- - Joseph Anthony Ferraro view on EDGAR
- - Michelle R. Ryan view on EDGAR
- - Stephanie Okey view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CTLT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CTLT with a 7-day demo
- CTLT on your watchlist
- Every CTLT Form 4 filing on record
- Up to 3 months of CTLT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
